These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 19645134

  • 21. [Changed diagnosis and treatment of hepatocellular carcinoma].
    van Nieuwkerk CM, Rauws EA, Tytgat GN, Reeders JW, Jones AE, Gouma DJ.
    Ned Tijdschr Geneeskd; 1996 Apr 27; 140(17):922-6. PubMed ID: 8676971
    [No Abstract] [Full Text] [Related]

  • 22. [Diagnosis and multimodal therapy for hepatocellular carcinoma].
    Kolligs FT, Hoffmann RT, op den Winkel M, Bruns CJ, Herrmann K, Jakobs TF, Lamerz R, Trumm C, Zech CJ, Wilkowski R, Graeb C.
    Z Gastroenterol; 2010 Feb 27; 48(2):274-88. PubMed ID: 20119895
    [Abstract] [Full Text] [Related]

  • 23. [Comparision of different interventional therapies for primary liver cancer].
    Liu YM, Qin H, Wang CB, Fang XH, Ma QY.
    Zhonghua Zhong Liu Za Zhi; 2007 Mar 27; 29(3):232-5. PubMed ID: 17649645
    [Abstract] [Full Text] [Related]

  • 24. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation.
    Yao FY, Hirose R, LaBerge JM, Davern TJ, Bass NM, Kerlan RK, Merriman R, Feng S, Freise CE, Ascher NL, Roberts JP.
    Liver Transpl; 2005 Dec 27; 11(12):1505-14. PubMed ID: 16315294
    [Abstract] [Full Text] [Related]

  • 25. Hepatocellular carcinoma: surgical treatment options.
    Gonzalez KB, Woodall M.
    Nurs Clin North Am; 2001 Sep 27; 36(3):593-602, xii. PubMed ID: 11532672
    [Abstract] [Full Text] [Related]

  • 26. [Effects of preoperative transcatheter artery chemoembolization on survival rate of hepatoma with percutaneous radiofrequency ablation].
    Zhou DW, Zhang ZJ, Sun W.
    Zhonghua Yi Xue Za Zhi; 2005 Mar 23; 85(11):786-8. PubMed ID: 15949389
    [No Abstract] [Full Text] [Related]

  • 27. [Diagnosis and treatment of hepatocellular carcinoma].
    Forner A, Ayuso C, Isabel Real M, Sastre J, Robles R, Sangro B, Varela M, de la Mata M, Buti M, Martí-Bonmatí L, Bru C, Tabernero J, Llovet JM, Bruix J.
    Med Clin (Barc); 2009 Feb 28; 132(7):272-87. PubMed ID: 19248879
    [No Abstract] [Full Text] [Related]

  • 28. Surveillance and diagnosis for hepatocellular carcinoma.
    Aljabiri MR, Lodato F, Burroughs AK.
    Liver Transpl; 2007 Nov 28; 13(11 Suppl 2):S2-12. PubMed ID: 17969087
    [No Abstract] [Full Text] [Related]

  • 29. Modern diagnosis and management of hepatocellular carcinoma.
    Marrero JA, Welling T.
    Clin Liver Dis; 2009 May 28; 13(2):233-47. PubMed ID: 19442916
    [Abstract] [Full Text] [Related]

  • 30. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B, Yu J, Wang L, Li C, Zhou T, Zhai L, Xing L.
    Am J Clin Oncol; 2003 Aug 28; 26(4):e92-9. PubMed ID: 12902905
    [Abstract] [Full Text] [Related]

  • 31. Hepatocellular carcinoma in viral hepatitis: improving standard therapy.
    Masuzaki R, Yoshida H, Tateishi R, Shiina S, Omata M.
    Best Pract Res Clin Gastroenterol; 2008 Aug 28; 22(6):1137-51. PubMed ID: 19187872
    [Abstract] [Full Text] [Related]

  • 32. Prognostic prediction and treatment strategy in hepatocellular carcinoma.
    Bruix J, Llovet JM.
    Hepatology; 2002 Mar 28; 35(3):519-24. PubMed ID: 11870363
    [No Abstract] [Full Text] [Related]

  • 33. Pretransplant treatments for hepatocellular carcinoma: do they improve outcomes?
    Di Bisceglie AM.
    Liver Transpl; 2005 Nov 28; (11 Suppl 2):S10-3. PubMed ID: 16237728
    [Abstract] [Full Text] [Related]

  • 34. Chemoembolization and bland embolization: a critical appraisal.
    Befeler AS.
    Clin Liver Dis; 2005 May 28; 9(2):287-300, vii. PubMed ID: 15831274
    [Abstract] [Full Text] [Related]

  • 35. [A case report of the local treatment against hepatocellular carcinoma (HCC) in consideration of the prospective living donor liver transplantation (LDLT)].
    Ishiko T, Beppu T, Doi H, Sugiyama S, Inomata Y, Egami H.
    Gan To Kagaku Ryoho; 2004 Oct 28; 31(11):1900-2. PubMed ID: 15553753
    [Abstract] [Full Text] [Related]

  • 36. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma.
    Llovet JM, Fuster J, Bruix J, Barcelona-Clínic Liver Cancer Group.
    Liver Transpl; 2004 Feb 28; 10(2 Suppl 1):S115-20. PubMed ID: 14762851
    [Abstract] [Full Text] [Related]

  • 37. Management of early hepatocellular carcinoma in patients with well-compensated cirrhosis.
    Cunningham SC, Tsai S, Marques HP, Mira P, Cameron A, Barroso E, Philosophe B, Pawlik TM.
    Ann Surg Oncol; 2009 Jul 28; 16(7):1820-31. PubMed ID: 19267161
    [Abstract] [Full Text] [Related]

  • 38. Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers.
    Tateishi R, Shiina S, Yoshida H, Teratani T, Obi S, Yamashiki N, Yoshida H, Akamatsu M, Kawabe T, Omata M.
    Hepatology; 2006 Dec 28; 44(6):1518-27. PubMed ID: 17133456
    [Abstract] [Full Text] [Related]

  • 39. [Hepatocellular carcinoma with extrahepatic malignancies].
    Yoshikawa K, Mikata S, Inoue M, Amemiya A, Iwasaki T, Moriguchi S, Emoto T, Han N, Itou A.
    Gan No Rinsho; 1990 Jan 28; 36(1):23-8. PubMed ID: 1688958
    [Abstract] [Full Text] [Related]

  • 40. Current strategy for staging and treatment: the BCLC update and future prospects.
    Forner A, Reig ME, de Lope CR, Bruix J.
    Semin Liver Dis; 2010 Feb 28; 30(1):61-74. PubMed ID: 20175034
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.